15 | Proteins (Proteins, Gene)FDA Link
10/2010
-
01/2000 |
11 | Messenger RNA (mRNA)IBA
10/2005
-
01/2000 |
7 | CytokinesIBA
02/2011
-
01/2000 |
7 | Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
04/2003
-
12/2000 |
7 | polysialyl neural cell adhesion moleculeIBA
01/2003
-
03/2001 |
6 | Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
01/2003
-
03/2001 |
5 | RNA (Ribonucleic Acid)IBA
12/2022
-
01/2000 |
5 | Protons (Proton)IBA
03/2009
-
08/2000 |
4 | Insulin (Novolin)FDA Link
10/2015
-
03/2000 |
4 | CholesterolIBA
09/2013
-
01/2003 |
4 | DNA (Deoxyribonucleic Acid)IBA
09/2013
-
01/2000 |
4 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2005
-
01/2001 |
4 | Caspase 3 (Caspase-3)IBA
08/2002
-
03/2000 |
4 | DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2001
-
06/2001 |
4 | Biotin (Vitamin H)FDA Link
10/2001
-
06/2001 |
3 | Biomarkers (Surrogate Marker)IBA
01/2018
-
01/2003 |
3 | CollagenIBA
12/2011
-
02/2000 |
3 | Peptides (Polypeptides)IBA
10/2010
-
07/2000 |
3 | Nerve Growth Factors (Neurotrophins)IBA
12/2006
-
10/2000 |
3 | ChemokinesIBA
02/2006
-
09/2000 |
3 | Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
11/2003
-
03/2002 |
3 | Latanoprost (Xalatan)FDA Link
08/2003
-
06/2001 |
3 | Bromodeoxyuridine (BrdU)IBA
09/2002
-
03/2001 |
3 | EnzymesIBA
03/2002
-
01/2000 |
3 | Complement System Proteins (Complement)IBA
07/2001
-
05/2000 |
2 | Anti-Bacterial Agents (Antibiotics)IBA
01/2020
-
11/2000 |
2 | Glucose (Dextrose)FDA LinkGeneric
02/2015
-
09/2013 |
2 | Neuroprotective AgentsIBA
09/2012
-
04/2003 |
2 | Adrenal Cortex Hormones (Corticosteroids)IBA
07/2011
-
01/2000 |
2 | LipidsIBA
02/2011
-
01/2003 |
2 | Thymidine PhosphorylaseIBA
07/2007
-
12/2002 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2006
-
06/2001 |
2 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2005
-
06/2001 |
2 | Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2005
-
04/2001 |
2 | oxidized low density lipoproteinIBA
10/2004
-
08/2000 |
2 | Bleomycin (Blenoxane)FDA LinkGeneric
07/2004
-
05/2000 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
04/2004
-
12/2001 |
2 | Thymidylate SynthaseIBA
11/2003
-
03/2002 |
2 | Fluorouracil (Carac)FDA LinkGeneric
11/2003
-
03/2002 |
2 | Ophthalmic Solutions (Eye Drops)IBA
08/2003
-
10/2001 |
2 | Antiglaucoma AgentsIBA
08/2003
-
10/2001 |
2 | LigandsIBA
06/2003
-
07/2000 |
2 | Liposomes (Liposome)IBA
04/2003
-
02/2000 |
2 | Telomerase (Telomerase Reverse Transcriptase)IBA
03/2003
-
01/2000 |
2 | Immunoglobulin G (IgG)IBA
11/2002
-
01/2000 |
2 | Amyloid beta-PeptidesIBA
08/2002
-
09/2000 |
2 | 1-methyl-1,2,3,4-tetrahydroisoquinolineIBA
11/2001
-
09/2001 |
2 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2001
-
07/2001 |
2 | Dopamine (Intropin)FDA LinkGeneric
11/2001
-
11/2000 |
2 | 1,2,3,4-tetrahydroisoquinolineIBA
11/2001
-
09/2001 |
2 | Immunoglobulin A (IgA)IBA
10/2001
-
07/2001 |